PortfoliosLab logoPortfoliosLab logo
PFE vs. ENB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PFE vs. ENB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pfizer Inc. (PFE) and Enbridge Inc. (ENB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PFE achieves a 8.09% return, which is significantly lower than ENB's 20.83% return. Over the past 10 years, PFE has underperformed ENB with an annualized return of 2.09%, while ENB has yielded a comparatively higher 9.33% annualized return.


PFE

1D
1.36%
1M
1.40%
YTD
8.09%
6M
3.39%
1Y
19.31%
3Y*
-6.48%
5Y*
-2.98%
10Y*
2.09%

ENB

1D
-0.76%
1M
6.41%
YTD
20.83%
6M
20.17%
1Y
27.79%
3Y*
21.89%
5Y*
14.70%
10Y*
9.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PFE vs. ENB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PFE
Pfizer Inc.
8.09%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%
ENB
Enbridge Inc.
20.83%19.51%26.35%-1.13%6.46%30.83%-13.60%36.05%-15.53%-2.73%

Correlation

The correlation between PFE and ENB is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Mar 28, 1990

0.18

The correlation between PFE and ENB shifts across timeframes, from 0.11 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

PFE:

$1.31

ENB:

$4.92

PE Ratio

PFE:

19.85

ENB:

11.44

PEG Ratio

PFE:

0.36

ENB:

0.52

PS Ratio

PFE:

2.35

ENB:

1.34

Total Revenue (TTM)

PFE:

$63.32B

ENB:

$69.05B

Gross Profit (TTM)

PFE:

$43.91B

ENB:

$15.35B

EBITDA (TTM)

PFE:

$16.94B

ENB:

$17.09B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PFE vs. ENB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PFE
PFE Risk / Return Rank: 6767
Overall Rank
PFE Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 6464
Sortino Ratio Rank
PFE Omega Ratio Rank: 6161
Omega Ratio Rank
PFE Calmar Ratio Rank: 7272
Calmar Ratio Rank
PFE Martin Ratio Rank: 7070
Martin Ratio Rank

ENB
ENB Risk / Return Rank: 8282
Overall Rank
ENB Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
ENB Sortino Ratio Rank: 8282
Sortino Ratio Rank
ENB Omega Ratio Rank: 7878
Omega Ratio Rank
ENB Calmar Ratio Rank: 8383
Calmar Ratio Rank
ENB Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PFE vs. ENB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Enbridge Inc. (ENB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PFEENBDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-0.97

Omega ratioGain probability vs. loss probability

1.17

1.29

-0.12

Calmar ratioReturn relative to maximum drawdown

1.79

2.96

-1.17

Martin ratioReturn relative to average drawdown

3.68

7.46

-3.78

PFE vs. ENB - Sharpe Ratio Comparison

The current PFE Sharpe Ratio is 0.86, which is lower than the ENB Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of PFE and ENB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PFEENBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.86

1.67

-0.81

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.12

0.79

-0.91

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.09

0.38

-0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

0.33

0.53

-0.19

Drawdowns

PFE vs. ENB - Drawdown Comparison

The maximum PFE drawdown since its inception was -69.24%, which is greater than ENB's maximum drawdown of -46.35%. Use the drawdown chart below to compare losses from any high point for PFE and ENB.


Loading charts...

Drawdown Indicators


PFEENBDifference

Max Drawdown

Largest peak-to-trough decline

-69.24%

-46.35%

-22.89%

Max Drawdown (1Y)

Largest decline over 1 year

-11.47%

-9.10%

-2.37%

Max Drawdown (3Y)

Largest decline over 3 years

-40.75%

-15.78%

-24.97%

Max Drawdown (5Y)

Largest decline over 5 years

-58.96%

-28.32%

-30.64%

Max Drawdown (10Y)

Largest decline over 10 years

-58.96%

-44.07%

-14.89%

Current Drawdown

Current decline from peak

-46.03%

-2.98%

-43.05%

Average Drawdown

Average peak-to-trough decline

-22.89%

-10.83%

-12.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.59%

3.63%

+1.96%

Volatility

PFE vs. ENB - Volatility Comparison

The current volatility for Pfizer Inc. (PFE) is 4.50%, while Enbridge Inc. (ENB) has a volatility of 5.79%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than ENB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PFEENBDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.50%

5.79%

-1.29%

Volatility (6M)

Calculated over the trailing 6-month period

14.66%

12.87%

+1.79%

Volatility (1Y)

Calculated over the trailing 1-year period

23.92%

16.13%

+7.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.50%

18.63%

+6.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.88%

24.33%

-0.45%

Dividends

PFE vs. ENB - Dividend Comparison

PFE's dividend yield for the trailing twelve months is around 6.61%, more than ENB's 4.93% yield.


PositionTTM20252024202320222021202020192018201720162015
ENB
Enbridge Inc.
4.93%5.66%6.28%7.31%6.80%6.85%7.55%5.58%6.68%4.71%4.13%4.71%
PFE
Pfizer Inc.
6.61%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%

Financials

PFE vs. ENB - Financials Comparison

This section allows you to compare key financial metrics between Pfizer Inc. and Enbridge Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B20222023202420252026
14.45B
22.36B
(PFE) Total Revenue
(ENB) Total Revenue
Values in USD except per share items

PFE vs. ENB - Profitability Comparison

The chart below illustrates the profitability comparison between Pfizer Inc. and Enbridge Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
67.3%
0
Portfolio components
PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.

ENB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Enbridge Inc. reported a gross profit of 0.00 and revenue of 22.36B. Therefore, the gross margin over that period was 0.0%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.

ENB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Enbridge Inc. reported an operating income of 3.23B and revenue of 22.36B, resulting in an operating margin of 14.4%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.

ENB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Enbridge Inc. reported a net income of 2.95B and revenue of 22.36B, resulting in a net margin of 13.2%.


Frequently Asked Questions


PFE and ENB have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ENB has higher volatility (5.79%) compared to PFE (4.50%). In terms of maximum drawdown, PFE dropped -69.24% vs ENB's -46.35%.

ENB currently has the higher Sharpe Ratio (1.67 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PFE and ENB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer